You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for Patent: 11,123,299


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,123,299
Title:Synthetic progestogens and pharmaceutical compositions comprising the same
Abstract: Described herein are synthetic progestogens, such as 6.beta.,7.beta.:15.beta.,16.beta.-Dimethylene-3-oxo-17.alpha.-pregn-4-ene- -21,17-carbolactone, as well as pharmaceutical compositions comprising the same. Also described are methods of use.
Inventor(s): Perrin; Philippe (Paris, FR), Velada; Jose Luis (Amersfoort, NL), Drouin; Dominique (Verrieres-le-Buisson, FR)
Assignee: LABORATORIOS LEON FARMA SA (Leon, ES)
Application Number:17/216,419
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Dosage form;

Drugs Protected by US Patent 11,123,299

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Exeltis Usa Inc DROSPIRENONE drospirenone TABLET, CHEWABLE;ORAL 216285-001 Jun 29, 2022 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Exeltis Usa Inc SLYND drospirenone TABLET;ORAL 211367-001 May 23, 2019 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,123,299

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 2588114 ⤷  Sign Up CA 2020 00023 Denmark ⤷  Sign Up
European Patent Office 2588114 ⤷  Sign Up 2020C/518 Belgium ⤷  Sign Up
European Patent Office 2588114 ⤷  Sign Up 19/2020 Austria ⤷  Sign Up
European Patent Office 2588114 ⤷  Sign Up C202030026 Spain ⤷  Sign Up
European Patent Office 2588114 ⤷  Sign Up 301123 Netherlands ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.